Skip to content

Opening book details…

About this Economics, Econometrics and Finance article

Bosutinib cost effective versus dasatinib and nilotinib in CML is a Economics, Econometrics and Finance article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.

Publisher
Springer Science and Business Media LLC
Published
2021
Field
Economics, Econometrics and Finance (Health Sciences)